[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6559-6560]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02401]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-22-0800]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Focus Group Testing to Effectively Plan and 
Tailor Cancer Prevention and Control Communications Campaigns'' to the 
Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on July 26, 2021 to obtain 
comments from the public and affected agencies. CDC did not receive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Focus Group Testing to Effectively Plan and Tailor Cancer 
Prevention and Control Communications Campaigns (OMB Control No. 0920-
0800, Exp. 10/31/2021)--Reinstatement with Change--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    The mission of the CDC's Division of Cancer Prevention and Control 
(DCPC) is to reduce the burden of cancer in the United States through 
cancer prevention, reduction of risk, early detection, and improved 
quality of life

[[Page 6560]]

for cancer survivors. Toward this end, the DCPC supports the scientific 
development and implementation of various health communication 
campaigns with an emphasis on specific cancer burdens.
    This process requires testing of messages, concepts, and materials 
prior to their final development and dissemination, as described in the 
second step of the health communication process. The health 
communication process is a scientific model developed by the U.S. 
Department of Health and Human Services' National Cancer Institute to 
guide sound campaign development. The communication literature supports 
various data collection methods to conduct credible formative, concept, 
message, and materials testing. This process ensures that the public 
clearly understands cancer-specific information and concepts, are 
motivated to take the desired action, and do not react negatively to 
the messages. CDC was previously approved to collect information needed 
to plan and tailor cancer communication campaigns (OMB Control No. 
0920-0800, Exp. 10/31/2021), and seeks OMB approval to revise the 
existing generic clearance to include another cancer-related 
communications campaign, expand the modes of data collection to include 
online focus groups and in-depth interviews (in-person, phone, and 
online), and to focus on respondents from the general public.
    Information collection will involve discussions to assess numerous 
qualitative dimensions of cancer prevention and control messages, 
including but not limited to, cancer knowledge, attitudes, beliefs, 
behavioral intentions, information needs and sources, and compliance 
with cancer screening as recommended by the United States Preventive 
Services Task Force. Insights gained from these discussions will assist 
in the development and/or refinement of future campaign messages and 
materials. Communication campaigns and messages will vary according to 
the type of cancer and the qualitative dimensions of the message 
described above.
    A separate information collection request will be submitted to OMB 
for approval of each discussion activity. The request will describe the 
purpose of the activity and include the customized information 
collection instruments. OMB approval is requested for three years. CDC 
requests OMB approval for an estimated 1,680 annual burden hours. 
Participation is voluntary and there are no costs to respondents except 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
General Public........................  Screening Form..........           1,600               1            3/60
General Public........................  Discussion Guide........             800               1               2
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-02401 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P